Skip to main content

Table 3 Differential expression of HCP5 in various cancers

From: LncRNA HCP5 as a potential therapeutic target and prognostic biomarker for various cancers: a meta‑analysis and bioinformatics analysis

Tumor Type

GSE ID

Sample size

Expression

P-value

Tumor

Normal

Breast cancer

GSE42568

104

17

High

0.0004

Triple-negative breast cancer

GSE76250

165

33

High

0.0001

GSE65194

55

11

High

0.0037

GSE65212

55

11

High

0.0037

Cervical cancer

GSE29570

45

17

High

0.0000

GSE63678

5

5

High

0.0007

GSE67522

20

22

High

0.0270

GSE39001

43

12

High

0.0376

Colon cancer

GSE28000

81

34

High

0.0152

GSE84984

7

6

High

0.0152

Esophageal tumor

GSE29001

21

24

High

0.0000

GSE5364

16

13

High

0.0053

Gastric cancer

GSE63089

45

45

High

0.0002

GSE49515

3

10

High

0.0004

GSE36076

3

9

High

0.0006

GSE58828

3

3

High

0.0040

GSE56807

5

5

High

0.0051

Liver tumor

GSE14520

225

220

High

0.0000

GSE11819

8

8

High

0.0000

Serous ovarian cancer

GSE36668

4

4

High

0.0016

GSE16708

17

9

High

0.0026

Bladder cancer

GSE89006

4

4

Low

0.0000

Ovarian cancer

GSE52037

10

10

Low

0.0001

GSE18520

53

10

Low

0.0003

Prostate cancer

GSE29079

47

48

Low

0.0000

GSE38241

18

21

Low

0.0000

GSE17951

109

45

Low

0.0006